MIP and infection: Using small molecule inhibitors designed to inhibit Mip, we demonstrated that treatment of B. pseudomallei-infected murine macrophages with the inhibitor AN_CH_37 resulted in a decrease in secreted pro-inflammatory cytokines IL-1β, TNFα and IL-6, and an increase in MCP-1, 24 hours post-infection.